Annual revenue:
N/ASummary
- DNLI annual revenue is not available.
Performance
DNLI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
N/ASummary
- DNLI quarterly revenue is not available.
Performance
DNLI Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
N/ASummary
- DNLI TTM revenue is not available.
Performance
DNLI TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
DNLI Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
DNLI Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
DNLI Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $330.53M(+204.7%) | - | - |
| Sep 2023 | - | $1.27M(-99.6%) | $340.81M(-0.7%) |
| Jun 2023 | - | $294.12M(+737.0%) | $343.11M(+238.2%) |
| Mar 2023 | - | $35.14M(+241.7%) | $101.46M(-6.5%) |
| Dec 2022 | $108.46M(+122.9%) | $10.28M(+188.9%) | $108.46M(-2.0%) |
| Sep 2022 | - | $3.56M(-93.2%) | $110.69M(-1.5%) |
| Jun 2022 | - | $52.48M(+24.5%) | $112.42M(+35.6%) |
| Mar 2022 | - | $42.14M(+236.8%) | $82.88M(+70.3%) |
| Dec 2021 | $48.66M(-85.5%) | $12.51M(+136.8%) | $48.66M(-86.2%) |
| Sep 2021 | - | $5.29M(-77.0%) | $352.96M(-1.2%) |
| Jun 2021 | - | $22.94M(+189.5%) | $357.07M(+5.0%) |
| Mar 2021 | - | $7.92M(-97.5%) | $339.98M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $335.66M(+1158.2%) | $316.81M(+3272.9%) | $335.66M(+1327.4%) |
| Sep 2020 | - | $9.39M(+60.6%) | $23.52M(-15.2%) |
| Jun 2020 | - | $5.85M(+62.2%) | $27.73M(+6.3%) |
| Mar 2020 | - | $3.60M(-22.9%) | $26.08M(-2.3%) |
| Dec 2019 | $26.68M(-79.3%) | $4.67M(-65.7%) | $26.68M(-81.9%) |
| Sep 2019 | - | $13.60M(+224.1%) | $147.68M(+9.2%) |
| Jun 2019 | - | $4.20M(-0.2%) | $135.27M(+1.9%) |
| Mar 2019 | - | $4.21M(-96.7%) | $132.72M(+2.8%) |
| Dec 2018 | $129.16M | $125.68M(>+9900.0%) | $129.16M(+3607.2%) |
| Sep 2018 | - | $1.20M(-27.5%) | $3.48M(+52.2%) |
| Jun 2018 | - | $1.65M(+157.1%) | $2.29M(+257.1%) |
| Mar 2018 | - | $641.00K | $641.00K |
FAQ
- What is the all time high annual revenue for Denali Therapeutics?
- What is the all time high quarterly revenue for Denali Therapeutics?
- What is the all time high TTM revenue for Denali Therapeutics?
What is the all time high annual revenue for Denali Therapeutics?
Denali Therapeutics all-time high annual revenue is $335.66M
What is the all time high quarterly revenue for Denali Therapeutics?
Denali Therapeutics all-time high quarterly revenue is $316.81M
What is the all time high TTM revenue for Denali Therapeutics?
Denali Therapeutics all-time high TTM revenue is $357.07M